CLINICAL RESEARCH & PRODUCT DEVELOPMENT ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About CLINICAL RESEARCH & PRODUCT DEVELOPMENT ApS
CLINICAL RESEARCH & PRODUCT DEVELOPMENT ApS (CVR number: 34214379) is a company from HOLBÆK. The company recorded a gross profit of -10.2 kDKK in 2019. The operating profit was -10.2 kDKK, while net earnings were -25.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -1.5 %, which can be considered poor and Return on Equity (ROE) was -8.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 43.2 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. CLINICAL RESEARCH & PRODUCT DEVELOPMENT ApS's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | -20.00 | -1.35 | -9.60 | -10.22 |
EBIT | -20.00 | -1.35 | -9.60 | -10.22 |
Net earnings | -34.00 | -15.13 | -23.71 | -25.15 |
Shareholders equity total | 360.00 | 344.42 | 320.70 | 295.56 |
Balance sheet total (assets) | 716.00 | 709.45 | 699.85 | 684.38 |
Net debt | - 712.00 | - 698.20 | - 686.60 | - 682.38 |
Profitability | ||||
EBIT-% | ||||
ROA | -2.8 % | -0.2 % | -1.4 % | -1.5 % |
ROE | -9.4 % | -4.3 % | -7.1 % | -8.2 % |
ROI | -5.6 % | -0.4 % | -2.9 % | -3.3 % |
Economic value added (EVA) | -20.00 | 16.34 | 8.18 | 8.16 |
Solvency | ||||
Equity ratio | 50.3 % | 48.5 % | 45.8 % | 43.2 % |
Gearing | ||||
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 2.0 | 1.9 | 1.8 | 1.8 |
Current ratio | 2.0 | 1.9 | 1.8 | 1.8 |
Cash and cash equivalents | 712.00 | 698.20 | 686.60 | 682.38 |
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | B | BB | BB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.